Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    9816238 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Phase II Study of Weekly Docetaxel and Topotecan in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Docetaxel;   Drug: Topotecan

Study has passed its completion date and status has not been verified in more than two years.